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Abstract
Background: The spindle assembly checkpoint is crucial for the maintenance of a stable chromosome number. Defects in
the checkpoint lead to Chromosomal INstability (CIN), which is linked to the progression of tumors with poor clinical
outcomes such as drug resistance and metastasis. As CIN is not found in normal cells, it offers a cancer-specific target for
therapy, which may be particularly valuable because CIN is common in advanced tumours that are resistant to conventional
therapy.
Principal Findings: Here we identify genes that are required for the viability of cells with a CIN phenotype. We have used
RNAi knockdown of the spindle assembly checkpoint to induce CIN in Drosophila and then screened the set of kinase and
phosphatase genes by RNAi knockdown to identify those that induce apoptosis only in the CIN cells. Genes identified
include those involved in JNK signaling pathways and mitotic cytoskeletal regulation.
Conclusions/Significance: The screen demonstrates that it is feasible to selectively kill cells with CIN induced by spindle
checkpoint defects. It has identified candidates that are currently being pursued as cancer therapy targets (e.g. Nek2: NIMA
related kinase 2), confirming that the screen is able to identify promising drug targets of clinical significance. In addition,
several other candidates were identified that have no previous connection with mitosis or apoptosis. Further screening and
detailed characterization of the candidates could potentially lead to the therapies that specifically target advanced cancers
that exhibit CIN.
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Introduction
Chromosomal INstability (CIN) is a common feature of nearly
all solid tumors [1]. CIN results in ongoing numerical and
structural aberrations of chromosomes as tumors proliferate, and is
associated with poor clinical outcomes such as tumour metastasis
and adaptability to environmental and chemical stresses [2,3].
Drug resistance and relapse is common in cancers with CIN as
they evolve rapidly, making them difficult to target with regular
therapies [4,5].
The most common errors seen in CIN cancer cells are lagging
chromosomes and chromosomal bridges. The mechanisms pro-
posed to be responsible for these errors include defects in: sister
chromatid cohesion [6], kinetochore–spindle attachment [7],
cytokinesis [8], and centrosome duplication [9]. Perhaps the
best-characterized cause of chromosomal instability is weakening
of the Spindle Assembly Checkpoint (SAC) [10,11].
The SAC is the only mechanism by which cells can detect
aberrant kinetochore attachments in metaphase and delay the
entry to anaphase until the problem is resolved, or otherwise
induce apoptosis [12,13]. This mechanism is not perfect, so
mutations that cause high rates of segregation defects or shorten
the duration of the metaphase error checking can cause CIN and
lead to tumorigenesis [10,11]. The list of mutations known to have
effects on chromosomal segregation is long, and includes over- and
under-expression of spindle checkpoint proteins and clinically
relevant cancer mutations such as loss of Rb in retinoblastoma or
Adenomatous Polyposis Coli (APC) in colorectal cancer [11,14].
Reduction of the SAC protein Mad2 (mitotic arrest deficient 2) or
its partner proteins (e.g. BubR1: Budding uninhibited by
benzimidazoles Related 1) have been shown to shorten metaphase,
causing CIN, aneuploidy and tumour susceptibility in humans and
mouse models [15–17]. However, even in those CIN cancers that
retain a SAC capable of detecting gross spindle abnormalities [18],
the checkpoint is not able to respond to the merotelic kinetochore
attachments that cause instability [19]. Loss of function of p53,
which is common in cancers [20], increases the tolerance level for
such missegregation, allowing the continual reassortment of the
genome seen in CIN tumours [21,22]. CIN levels are higher in
malignant tumors than in benign ones [23,24] and CIN is not
found in normal cells, so it offers an attractive target for a cancer-
specific therapy. CIN is particularly common in tumour types that
are most in need of new drugs (e.g. colorectal cancers). Targeting
CIN could also help to limit the ability of cancer cells to evolve
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drug resistance and other poor clinical outcomes, which may
increase the efficacy of current therapies.
Here we have used depletion of the SAC to induce CIN. We
have then carried out a systematic genome-wide screen for kinase
and phosphatase genes that, when depleted, can trigger apoptosis
only in these genetically unstable cells, but not in normal cells. Our
rationale is that for a therapy to be effective, cell death should be
restricted to the tumour, i.e. the cells that exhibit CIN. We set up
an assay system using Drosophila melanogaster in which we induced
tissue-specific chromosomal instability in a wild type organism. We
generated CIN by knocking down the SAC protein Mad2, which
shortens metaphase, giving cells less time to correctly orient their
chromosomes before the onset of anaphase [25], resulting in
chromosomal bridges and lagging chromosomes. While there may
be numerous defects that lead to CIN in a tumour, loss of Mad2 is
found as a contributing factor in a range of CIN cancers [26,27]
and more than 80% of colorectal cancers carry APC mutations
that have been shown to sequester Mad2 [28] and BubR1 [29] at
least in some cell lines [30].
Kinases and phosphatases are key regulatory enzymes control-
ling vital processes such as cell growth, differentiation, and survival
[31]. Alteration in levels of these proteins can lead to abnormal cell
growth and cell death mechanisms, which can result in tumori-
genesis [32]. Many kinases and phosphatases are approved as
good drug targets and currently they are the main focus of drug
discovery efforts against cancer [33]. Our screening of kinase and
phosphatase genes in a CIN background gave a set of potential
candidates that reproducibly caused significant lethality via
apoptosis in CIN flies compared to their non-CIN control siblings.
The screen identified several groups of candidates including
Figure 1. Establishment of a screening strategy using an induced-CIN model. (a) Reverse transcriptase-qPCR shows that the ubiquitous
expression of UAS-mad2 RNAi resulted in ,85% knocked down of mad2 expression level (black bar) which is significantly less than the mad2 level in
UAS-LacZ RNAi control (grey bar). Error bars represent SD. P-values are calculated by two-tailed Student’s t-test: p,0.001 =www. (b–c) Third instar
larval brain cells stained with Hoechst 33342 to label DNA. (b) Normal segregation in a wild type anaphase. (c) Defective anaphase in an induced-CIN
brain cell (da.mad2) resulting in a lagging chromosome (arrowed). (d) The fraction of defective anaphases (lagging chromosomes or bridges)
observed in mad2 knocked down (black bar) brain squashes and wild type controls (grey bar). Error bars represent 95% CIs. P-values are calculated by
two-tailed Fisher’s exact test: p,0.001 =www. (e) Diagrammatic representation of viability screen crosses. Males with Kinase-RNAi (UAS-kinasedsRNA)
were crossed with females carrying the CIN background (UAS-mad2dsRNA; da-Gal4). Progeny were double knockdown (A: mad2 and kinase) or single
knockdown (B: kinase only). The ratio of viable progeny A/B was used to rank candidates for further analysis.
doi:10.1371/journal.pone.0047447.g001
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centrosomal proteins such as Nek2, which is currently being
pursued as a therapeutic target for cancer [34]. These results may
contribute to the identification of novel targets that can specifically
kill advanced, drug resistant, CIN tumor cells without harming
normal cells.
Results
Screening for Candidate Knockdowns that Kill Cells with
SAC-induced Chromosomal Instability
To generate a model system in which we could induce
chromosomal instability we expressed dsRNA to knock down
Mad2 and thereby weaken the SAC in Drosophila. Ubiquitous
expression of mad2 dsRNA in the whole organism gives ,85%
reduction of Mad2 expression as compared to control lacZ dsRNA
(Figure 1a). This depletion of Mad2 resulted in .25% of
anaphases showing lagging chromosomes or chromosomal bridges
in larval brains (Figure 1b–d), without compromising the overall
viability of the organism. This survival, despite a significant rate of
anaphase errors, is consistent with the viable amorphic mad2 allele
described by Buffin et al. [25]. We used this background to screen
a set of gene knockdowns to identify candidates that could
specifically kill cells with CIN but not normal dividing cells. We
screened the Drosophila kinome, testing knockdown of 397 kinase
and phosphatase genes for those that were lethal only in a CIN
background (Figure 1e). This screening ranked the set of genes to
identify those that when depleted in the whole organism,
reproducibly caused the most lethality in CIN flies compared to
their non-CIN control siblings (Table S1). The siblings vary only
in whether or not they have induced CIN, so a deviation from the
expected 1:1 ratio of CIN: non-CIN progeny indicated a CIN-
specific effect of the candidate on viability. We observed the whole
range of responses from complete lethality in a CIN background
through to no effect, and we prioritized those candidates with the
strongest CIN-specific lethality.
Screening for Cell Death
We investigated the cellular phenotypes of 26 kinases from the
initial screen that gave more than 75% lethality in a CIN
background, that is, more than four non-CIN for every one
surviving CIN sibling. This lethality could have resulted from
developmental or patterning failures, so we wished to test whether
our candidates generated cell death in CIN cells. First, we
examined the effect on wing development when candidates were
depleted with or without mad2 (Figure S1a), and these data were
quantified by measuring the amount of tissue loss (notching) in the
affected wing area (Figure S1b). 17 candidates resulted in
significant cell loss in adult wings when Mad2 was reduced as
compared to controls (Table 1). The most promising candidates
identified from this screening included genes from some well
characterized groups such as those involved in JNK (Jun N-
terminal kinase) signaling and centrosomal regulation as well as
others (e.g. PAS Kinase) with no previous connection to cell
division.
Acridine Orange staining of larval wing discs showed signifi-
cantly elevated levels of cell death when the candidates were
knocked down in CIN cells (e.g. Figure 2), consistent with the wing
tissue loss being caused by cell death in the affected region.
Quantification of the Acridine Orange stains was carried out by
measuring the average signal per unit area in each half of the disc
and subtracting the background value (from the wild type, control
half) from the RNAi affected half, to show the effect of the
knockdown. This gave data consistent with the adult wing tissue
loss results (complete data shown in Figures S2a and S2b). Note
that loss of Mad2 by itself gave little cell death (Figure 2a’; [25]), as
did depletion of the candidates alone (Figure 2b, 2c), consistent
with these candidates only being required for the survival of
genetically unstable cells. To validate our model we induced CIN
by knocking down another SAC protein, BubR1 [35], and found
that our candidates also induced cell death in this CIN
background (e.g. Figure S4). Interestingly, not all candidates
showing a high level of cell death in a CIN background were
completely depleted by the candidate-RNAi. For example, bsk and
asp knockdown still left 46% (64%) and 63% (63%) respectively
of the wild type RNA levels when measured by qPCR. This partial
knockdown was expected for essential genes like bsk and asp,
because our original screen selected for candidate RNAi lines that
were not lethal in normal cells. CIN cells must be highly sensitive
to dosage variations in these candidates to give such strong
phenotypes following modest candidate depletion, emphasizing
the significant role these candidates have in cellular responses to
CIN.
Apoptosis in CIN Cells
To confirm that the cell death observed was a result of the
activation of apoptosis, we used antibody staining for the active
form of effector caspase 3 (Figure 2e). Consistent with the results of
Acridine Orange staining, knockdown of either Mad2 or a
candidate alone showed little apoptosis-specific cleaved caspase 3
staining. However when we knocked down both mad2 and a
selected candidate (e.g. asp: abnormal spindle) we observed apoptosis
in the affected area (dark staining in Fig. 2e’’). Similar caspase
results were seen for other candidates (data not shown). Together,
these results suggest that knockdown of the candidates from our
screen does not kill normal cells but does cause cell death by
apoptosis in these CIN cells. This apoptosis could result if the
candidate knockdowns generated CIN themselves, as high levels of
CIN can be cell-lethal [36]. To test whether loss of our candidates
induced apoptosis by increasing the level of CIN over a viability
threshold, we tested whether their depletion induced CIN in
normal cells by scoring mitotic cells from larval brains. We did not
see any significant increase in anaphase errors (Figure S5),
suggesting that depletion of the candidates alone does not generate
CIN.
Involvement of DNA Damage
Because double-stranded DNA breaks are a well known cause of
anaphase errors and are implicated in p53 dependent cell death
[37,38], we tested for DNA damage by anti-cH2aX antibody
staining in knockdowns of selected candidates with and without
Mad2 in larval wing discs (Figure 3). Depletion of Pask, bsk, loki,
Nek2, CG8878, asp, mbt or CG4041 in CIN cells gave an elevated
level of DNA damage, compared to the lacZ RNAi negative
control (Figure S3). Other candidates such as aPKC, when depleted
in CIN cells, did not show a significantly elevated level of DNA
damage as compared to the negative control (Figure S3), although
they showed a high level of apoptosis (Figure S2A). In contrast,
DNA damage in Pask (PAS kinase) depleted CIN cells was
significantly higher than aPKC and Nek2 (Figure 3 and S3),
although Pask showed lower levels of apoptosis. Our results show
that the CIN dependent apoptosis generated by candidate
depletion was often, but not always, associated with an increase
in double stranded DNA breaks.
P53 Dependence for Induced Cell Death in CIN Cells
Because P53 is commonly lost in tumours and has been
implicated in their CIN tolerance [21,22], we tested the effect of
P53 knockdown in several candidates from our screen. Specifical-
Killing Cells with Chromosomal Instability
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ly, we examined whether loss of P53 affected the ability of our
candidates to induce cell death in a CIN background. Depletion of
P53 suppressed the loss of tissue phenotype when Pask and mad2
were both depleted in adult wings (data not shown) and
significantly decreased the level of apoptosis in wing discs
(Figure 4), suggesting that the cell death in this case was largely
p53 dependent. However for asp, depleting P53 had little effect in
the double knockdown (asp and mad2) wing discs, showing that, in
this case, the apoptosis induced by asp knockdown in CIN cells is
largely P53 independent (Figure 4). Other candidates such as bsk
(Jun kinase) gave a modest reduction in the level of cell death when
P53 was depleted (data not shown), suggesting the involvement of
both p53 dependent and independent mechanisms in inducing cell
death in this case.
Discussion
To identify targets that could be depleted to induce apoptosis in
cells with chromosomal instability, we carried out RNAi screening
of kinases and phosphatases in a CIN model system. We targeted
CIN because it is common in cancers and CIN makes these
cancers resistant to current therapies [3]. Using Drosophila as a
model, we were able to induce CIN in a genetically stable
background by depleting ,85% of Mad2, which weakens SAC
function and shortens metaphase [25,39]. We found this gives an
optimal level of CIN that is enough to screen against, but not so
much that cells cannot survive. This approach has some
advantages over using vertebrate CIN cell lines [40] which, by
definition, have highly diverse and unstable genomes. In
particular, we were able to test each candidate on genetically
identical control tissues, which allowed us to be confident that any
apoptosis was due to the effect of the checkpoint defect, not an
artifact of a particular aberrant cell line.
The screen identified a significant group of candidates,
including Nek2, JNK and Asp, that are directly or indirectly
linked to the centrosome (Table 1). The centrosome is a regulatory
hub of the major events during mitosis: alterations in centrosomal
proteins and numbers result in segregation defects and CIN [41].
Extra centrosomes are common in cancer, and contribute to CIN
by forming multi-polar spindles, which produce more merotely
and lagging chromosomes and hence whole chromosome aneu-
ploidy [42,43]. Our identification of Nek2, which is currently
being pursued as therapeutic target for cancer [34], confirms that
our screen has the potential to identify clinically significant drug
targets for CIN tumors.
Members of the JNK pathway, which is known to promote
apoptosis, DNA damage response, proliferation, migration and
differentiation [44–46] were also found in our screen. Our results
suggest a novel role for JNK in preventing cell death in response to
mitotic errors. This may potentially explain the anti-apoptotic
effect of JNK seen in HCC tumours and leukemia [44].
Abnormal spindle (Asp) binds at the minus end of microtubules,
and is required for centrosome attachment [47] and possibly for
down-regulating p53 [48]. In this respect it is interesting that we
observed p53 independent cell death in asp mad2 double
depletions. This suggests that the apoptosis we observed was not
simply a result of losing a negative regulator of p53. Further work
will be required to determine what triggers cell death in this case.
Taken together, these results suggest that CIN cells are highly
sensitive to centrosome disruption, responding by apoptosis to
treatments that have no effect on normal dividing cells. One
Table 1. Candidates giving CIN-dependent cell death.
Groups
Candidate
symbol Mammalian homolog Functional association
Centrosomal Nek2 NIMA-related kinase 2 (NEK2) Cell cycle progression [61]
lok checkpoint homolog (Chk2) DNA damage [62]
asp Abnormal spindle (Aspm) Spindle organization [47]
tefu Ataxia telangiectasia mutated (ATM) DNA damage response [62]
bsk JUN amino terminal kinase (JNK) JNK signaling pathway [63]
JNK pathway bsk JUN amino terminal kinase (JNK) JNK signaling pathway [63]
pvr PDGF/VEGF receptor JNK activator [64]
slpr JUN kinase kinase kinase (JNKKK) JNK signaling pathway [65]
Pak3 p21 protein (Cdc42/Rac)-activated kinase 3 (PAK3) JNK activator [66]
DNA damage lok checkpoint homolog (Chk2) DNA damage [62]
tefu Ataxia telangiectasia mutated (ATM) DNA damage response [62]
Wnt signaling pathway mbt p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4) Wnt signaling/cytoskeletal regulation [67]
aPKC Protein kinase C Wnt signaling [68]
Wnk WNK lysine deficient protein kinase 1 (WNK1) Ion regulation, cell cycle progression and adaptation [69]
Histone kinases CG8878 vaccinia-related kinase (VRK)? Histone kinase?
ball Nucleosomal histone kinase-1 (Nhk-1) Histone kinase [70]
Others Pink1 PTEN-induced putative kinase 1 apoptosis/mitophagy [71]
lic mitogen-activated protein kinase kinase 3 (MAP2K3) MAP kinase-mediated signaling [72]
CG4041 TBC1 domain containing kinase (TBCK)/Rab gtpase? Unknown
Pask PAS kinase (PASKIN) cellular energy homeostasis [52,53]
Candidates from the viability screening and cell death assay that gave the most CIN-dependent cell death. Some of the candidates are placed in more than one group
on the basis of their associations.
doi:10.1371/journal.pone.0047447.t001
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plausible hypothesis to explain this sensitivity was that the
centrosome disruption by itself caused a certain rate of CIN,
which when added to the CIN from Mad2 depletion, took the cells
over a threshold of instability beyond which they were unviable
[36]. Our data do not support this model, as we did not detect a
significant rate of anaphase errors when any of our centrosomal
candidates were depleted by themselves (Figure S5). An alternative
explanation is that there is significant crosstalk between events at
Figure 2. Cell death assays on larval wing discs. Dotted line shows the en-CD8GFP marked compartment or tester region in which genes were
depleted. The other half of each wing disc expressed no transgenes and serves as an internal control. (a–c, a9–c9) Images of wing discs stained with
Acridine Orange to show cell death. (a) Negative control (lacZ RNAi), (a9) LacZ and mad2 RNAi, (b & c) Candidate RNAi (asp and bsk), (b9 & c9) double
knockdown of candidate and Mad2. (d) Graph shows quantitation of Acridine Orange staining (above wild type) in control and candidate imaginal
wing disc halves with or withoutmad2 RNAi. Error bars represent 95% CIs, n$8 in all cases. P-values were calculated by two-tailed t-tests with Welch’s
correction: p,0.001 =www. (e-e9) Cleaved caspase 3 staining showing apoptosis in e: mad2 RNAi, e9: asp RNAi and double knockdown (e0: asp RNAi
and mad2 RNAi).
doi:10.1371/journal.pone.0047447.g002
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the centrosome and events at the kinetochore that renders SAC-
deficient cells particularly dependent on centrosomal signals. This
dependence may relate to the centrosomal localization of p53
[48,49], DNA damage repair proteins [50] or even Mad2 itself
[51].
Several interesting candidates identified in our screen,
however, are not localized on centrosomes (e.g. Pask and
aPKC). Furthermore, some candidates have no reported
connection of any kind with mitosis, indicating that we may
have detected novel pathways that sense segregation defects and
provide stability to cancer cells against CIN. For example, Pask
is a serine/threonine kinase involved in sensing and regulating
cellular energy homeostasis [52,53]. Here we show its novel role
in preventing DNA damage and p53 dependent apoptosis in
CIN cells. Our screen also isolated candidates that are involved
in the DNA damage response (tefu, lok, bsk, and pp1a), suggesting
a role for the DNA damage response pathway in responding to
CIN. This is not surprising given the recent work showing that
anaphase errors result in DNA damage [36,54] and the role of
Mad2 in delaying anaphase onset to give time for repair [55].
It seems clear that the DNA damage we observed in our
candidates in the presence of CIN is not simply part of the
apoptotic program: we see strong apoptosis and little DNA
damage in aPKC knockdown in CIN cells. Furthermore our
highest levels of DNA damage were seen in Pask mad2 double
depletions, which gave no more apoptosis than aPKC. It is striking
that none of our candidates alone, nor mad2 alone, gives significant
levels of DNA damage. Our interpretation of this is that the
cellular DNA damage response can keep the level of damage
below our detection sensitivity in any of the single depletions, and
it is only when multiple checkpoint and repair mechanisms are
depleted that we see unrepaired damage and widespread
apoptosis.
Depletion of Asp or Bsk gives some P53 independent apoptosis
in CIN cells, which could make them desirable therapeutic
candidates in a clinical setting, where P53 is often absent [56], and
indeed JNK inhibitors are currently in clinical trials [57].
Unfortunately, JNK is involved in many processes that make it
problematic as a drug target [58]. However, the other candidates
that regulate JNK signaling, (Hep: hemipterous/JNKK, Slpr: slipper/
JNKKK, Pak3/Pak2 and Pvr: PDGF/VEGF receptor), may have
potential as good CIN-specific targets.
In summary, we have used a new model for CIN in Drosophila
to demonstrate the principle that it is possible to selectively kill
CIN cells. Our RNAi knockdown identified candidates not
previously known to have mitotic roles but whose depletion has
the potential to kill proliferating CIN cells. Further character-
ization of screened candidates and their pathways may help to
Figure 3. DNA damage (anti-P-H2AvD) staining of third instar larval wing discs. (a–c9) Dotted line shows the en-CD8GFPmarked test region
in which genes were depleted. The other half of each wing disc expressed no transgenes. (a, a9) Negative control (LacZ RNAi) with and without Mad2
(b, b9) PASK depletion with and without Mad2. (c, c9) aPKC depletion with and without Mad2. Significant induction of DNA damage in the depleted
area is seen in Pask, mad2 discs but not LacZ, mad2 or aPKC, mad2 discs.
doi:10.1371/journal.pone.0047447.g003
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identify mechanisms by which cancer cells can tolerate the
adverse effects of CIN and aneuploidy which in turn may lead
to the identification of novel targets that can specifically kill
advanced, drug resistant, CIN tumor cells without harming
normal cells.
Figure 4. P53-dependent and p53-independent apoptosis. (a–d) Dotted line shows the en.CD8GFP marked test region and the other half
expressed no transgenes. Acridine Orange staining on double (a–b: Candidate and mad2) and triple knockdown (c–d: Candidate, mad2 and p53) wing
discs. (e) Graph shows quantitation of Acridine Orange staining (above wild type) in control and candidate knocked down imaginal wing disc halves.
The first bar of each group represents candidate RNAi alone (control), the second bar represents candidate RNAi with p53RNAi (P53), the third or black
bar represents Candidate and mad2 knocked down and the fourth bar represents triple knockdown (Candidate, mad2 and p53). Error bars represent
95%CIs, n$8 in all cases. P-values are calculated by two-tailed t-tests with Welch’s correction: p,0.001 =www and p.0.05 = ns (not significant).
Tests compare candidate mad2 p53 with candidate alone to test whether significant p53-independent cell death is seen when each candidate is co-
depleted with Mad2. Significant levels of p53-independent cell death are seen for asp, mad2 but not Pask, mad2.
doi:10.1371/journal.pone.0047447.g004
Killing Cells with Chromosomal Instability
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Materials and Methods
Stocks
All UAS-RNAi lines used, including 485 UAS- Candidate RNAi
(kinase and phosphatase) lines, were obtained from the Vienna
Drosophila RNAi Centre. The mad2-RNAi line used was v47918.
Ubiquitous expression was driven using daughterless (da)-Gal4 and
posterior wing disc expression was driven using engrailed (en)- or
hedgehog (hh)-Gal4 (Bloomington stock center).
Screening
In viability screening we have tested ubiquitous (da.Gal4)
knockdown of candidates (the kinase and phosphatase genes, see
Table S1) in the CIN background (mad2 RNAi): UAS.mad2-
RNAi/CyO; da.Gal4/TM6 tub.Gal80ts 6 UAS. candidate-
RNAi. The temperature of crosses was adjusted to give the best
numbers of progeny while still getting effective knockdown (mostly
23uC). The ratio of the average viable fly count of double
knockdown (mad2 and candidate) over single knockdown (candidate
only) progeny gave the level of viability of that candidate in CIN
flies. Depletion of candidates that gave .75% lethality when mad2
was co-depleted, compared to the candidate knockdown alone,
were retested and, if reproducible, considered for further assays.
This was measured by counting the number of surviving Cy versus
non-Cy progeny from each cross, selecting those with a ratio of at
least 4:1.
RNA Purification and Quantitative Real-time PCR (qPCR)
Assays
For each genotype, thirty brains or sixty imaginal wing discs
from third instar larvae were dissected in 1X PBS and quickly
transferred and homogenized into pre-cooled Trizol reagent
(Invitrogen). This was done in three biological replicates. Samples
were then frozen in liquid nitrogen and kept in 280 C until RNA
extraction. Total RNA was extracted with chloroform and
precipitated with ethanol. RNA was further purified using the
RNeasy Mini Kit (Qiagen).
The qPCR assays were carried out using protocols described in
[59]. Each reaction was done in triplicate for all biological
replicates. Superscript III (Invitrogen) was used to make cDNA
and the relative quantitation was done by using the SYBR Green
mix and ABI Prism 7000 Sequence Detection System (Applied
Biosystems). The mRNA levels were normalized by the mRNA
levels of house-keeping gene ribosomal protein 49 (rp49) from
Drosophila.
Primers Pairs for Drosophila Mad2, Pask and Bsk qPCR
Assay
mad2 F/R: GGCGACCAAAAACTGCATCA/GGTAAATT-
CCGCGTTGGAAGA, bsk F/R: GAATAGTATGCGCCGCT-
TACGA/ATTCCCTATATGCTCGCTTGGC, asp F/R: AGG-
CAAAGGCGGTAAACTCTGT/ACTCCGAACACCACATG-




Loss of tissue in the posterior compartment of adult wings was
scored by measuring the distance from where the fifth vein met the
margin, to the fourth vein. Wings of adult females were dissected
in ethanol and mounted in Aqua Poly/Mount (Polysciences, Inc.).
Levels of CIN were tested by counting defective anaphases in
fixed, Hoechst 33342 stained brain squashes as described [60].
Briefly, third instar larval brains were dissected in PBS, fixed for 30
minutes in 4% formaldehyde, then treated with 45% acetate for 30
seconds and put into a drop of 60% acetate for 3 minutes before
squashing, freezing in liquid nitrogen and leaving in ethanol until
staining with 5 ug/ml Hoechst 33342 in PBS plus 0.2% Tween20,
then washing with PBST and mounting in 80% glycerol. All clear
anaphases in each brain were photographed and scored as normal
or defective. Defective included those with bridges, broken bridges
or lagging chromosomes. Slides were coded and scored without
knowing their genotype.
Cell death in 3rd instar larval imaginal wing discs was measured
using a vital stain (Acridine Orange). Third instar larvae were
selected and dissected, and imaginal discs were collected carefully
in PBS. Imaginal wing discs were then incubated for 2 min in a
1 mM Acridine Orange solution and briefly rinsed in PBS before
immediately mounting and imaging. The discs were transferred to
a slide having double sided sticky tape on either side of the sample.
This was done to prevent the squashing of discs when we placed a
cover slip on top. Acridine staining was normalized by subtracting
the mean intensity value of the wild type anterior compartment
from the mean intensity value of the mutant posterior compart-
ment (marked with en.CD8GFP), using ImageJ software. Before
normalization, background noise was subtracted from all the
images by setting the rolling ball radius at 10 pixels.
Cleaved caspase 3 immunostaining was performed on dissected
wing imaginal discs. Single and double knockdown third instar
larvae were selected and dissected in PBS and fixed in 4%
formaldehyde for 20 minutes. Fixed discs were extensively washed
with PBST (1xPBS+0.2% Tween) and then blocked by PBST
containing 5% fetal calf serum (PBSTF) for 30 minutes. Discs were
then incubated in primary antibody solution (1:100 Cleaved
Caspase 3 Antibody from Cell Signaling in PBSTF) for 2.5 hrs at
room temp or left overnight at 4uC followed by 2–3 quick washes
with PBSTF and then 30 minutes in PBSTF. For secondary
antibody staining, discs were incubated for 2 hrs in the dark at
room temperature with 1:75 Anti rabbit CY-3 Antibody from
Abacus/Jackson in PBST followed by 2–3 quick washes with
PBST and then 30 minutes incubation in PBST. Mounting was
done with 80% glycerol-PBS. DNA damage staining was done
using the same method with rabbit anti-H2AvD P-Ser137 (1:700;
Rockland) which is the Drosophila equivalent of vertebrate cH2aX,
and anti-rabbit Cy3-conjugated secondary antibody (1:100;
Abacus/Jackson). Quantitation of DNA damage staining (anti-P-
H2AvD) was also done on normalized mean intensity value.
Normalization was done by subtracting the mean intensity value of
the wild type anterior compartment from the mean intensity value
of the mutant posterior compartment (marked with en.CD8GFP),
using ImageJ software. Before normalization, background noise
was subtracted from all the images by setting the rolling ball radius
at 5 pixels. All microscopy was done on a Zeiss Axioplan2 with
Semrock Brightline filters and measurements and quantitation
were done using Axiovision software (Carl Zeiss). Images were
compiled using Axiovision (Carl Zeiss), Photoshop and Illustrator
(Adobe) software.
Supporting Information
Figure S1 a. Loss of tissue in adult wings. Engrailed-driven
single (candidate-RNAi only) and double (candidate and mad2-RNAi)
knockdown in adult Drosophila wings. This driver depleted genes
only in the posterior compartment of the wing, the lower half of
each wing in this figure. We measured the loss of tissue by
measuring the shortest distance from where the fifth longitudinal
vein met the margin, to the fourth longitudinal vein (arrows).
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Depletion of Pask shows posterior wing margin notching
(arrowheads) along with shorter inter-vein distance (see Figure
S1b), when co-depleted with mad2 RNAi. Figure S1 b:
Quantification of loss of tissue in adult wings: Graph shows the average
distance between 4th and 5th vein of adult wings as in S1a, which
measures loss of tissue in the engrailed test region. Light grey bars
represent candidate RNAi alone, dark grey bars show double
knockdowns (candidate RNAi with mad2 RNAi). Negative control
(W1118) showed no significant tissue loss with (black bar) or without
CIN. The Y-axis starts from 250 mm, to improve resolution.
dWNK was an outlier not included in this graph, showing an
inter-vein distance without and with mad2 RNAi of 245 mm and
60 mm respectively. Error bars represent 95%CIs, n$8 in all
cases.
(PDF)
Figure S2 a:Quantitation of Acridine Orange staining
on larval wing discs. Graph shows quantitation of Acridine
Orange staining of control and candidate-RNAi imaginal wing
discs. Quantification shows arbitrary grey value units normalized
by subtracting the mean grey value of the wild type (anterior)
region from the mean grey value of the affected (posterior) region
for each disc. Negative control (LacZ RNAi) and candidate RNAi
alone are represented in light grey bars and the double
knockdowns of candidates with mad2 are represented by dark
grey bars, while double knockdown of mad2 with the LacZ negative
control is shown in black. Error bars indicate 95%CIs, n$8 in all
cases. P-values are calculated by two-tailed t-tests with Welch’s
correction: p,0.001=www, p 0.00120.01=ww, p
0.0120.05=w. All t-tests compare candidate-RNAi mad2-RNAi
with lacZ-RNAi mad2-RNAi. Figure S2. (b1–b4):Acridine
Orange staining on larval wing discs (complete data).
All wing discs are stained with Acridine Orange and the dotted
line shows the en.CD8GFP marked posterior compartment or test
region in which the genes were depleted. The other half of each
disc expressed no transgenes. Single knockdowns of each
candidate are arranged on the right and the double knockdowns
with mad2 are on the left side. Representative discs for each
genotype are shown; the level of variation for each genotype can
be seen in Figure S2A.
(PDF)
Figure S3 DNA damage staining quantitation. Graph
shows a quantitative analysis of DNA damage (anti-P-H2AvD
staining). The Y-axis represents the level of P-H2AvD staining in
the affected half normalized by subtracting the level in the control
half for each disc. Light grey bars represent the candidate
knockdown in wild type background and dark grey bars represent
the double (candidate and mad2) knockdown. Error bars indicate
95%CIs, n$8 in all cases. P-values are calculated by two-tailed t-
tests with Welch’s correction: p,0.001=www, p 0.0120.05=w
and p.0.05 =ns (not significant).
(TIF)
Figure S4 Cell death assay for the validation of Mad2
results with BubR1. Dotted line shows the en.CD8GFP region
or tester region and the other half expresses no transgenes (a-f)
Images of wing discs stained with Acridine Orange. (a) mad2 RNAi
(d) bubR1 RNAi. (b & e) Pask RNAi. Double knockdowns are (c):
Pask RNAi and mad2 RNAi and (f): Pask RNAi and bubR1 RNAi.
(TIF)
Figure S5 CIN levels. Graph represents the frequency of
defective anaphases in knockdowns of LacZ, Asp, Bsk, aPKC, Pask
and Mad2 in brain cells. LacZ was used as a negative RNAi
control and Mad2 is used as positive control to compare the level
of CIN. None of the candidates show significantly elevated levels
of CIN above the LacZ control. Error bars show 95%CIs, n.40 in
all cases. P-values are calculated by two-tailed Fisher’s exact test:
p,0.001=www (extremely significant) and p.0.05= ns (not
significant).
(TIF)
Table S1 List of kinases and phosphatases tested in the
viability screening of our induced-CIN model. Columns
show: the gene identifiers; number of replicate crosses carried out;
total numbers of CyO (kinase-RNAi only) and non-CyO (kinase,
mad2 RNAi) progeny; Ratio of the average number of Cy/non-Cy
progeny per cross used to rank the table; and probability of finding
a cross this diverged or more diverged from a 50/50 ratio (the null
hypothesis), out of this number of crosses (936), purely by chance.
(XLSX)
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